Welcome to our dedicated page for Medtronic SEC filings (Ticker: MDT), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Medtronic plc filings document material events, capital structure, registered securities, governance matters, and operating and financial disclosures for a medical-device company organized in Ireland. The 8-K record identifies MDT ordinary shares and multiple series of senior notes listed on the New York Stock Exchange, alongside current reports used for company events and financial-result communications.
The filing record also includes exchange and registration status for debt securities, including a Form 25 notice tied to removal from listing and registration of a guarantor class of senior notes. These disclosures frame Medtronic's public-company obligations around equity, debt instruments, material agreements, and regulatory or clinical developments.
Medtronic plc (MDT) – Form 4 filing: EVP Global Operations & Supply Chain Gregory L. Smith reported an automatic share withholding related to tax obligations on 31 Jul 2025.
- Transaction code F indicates 1,630 ordinary shares were surrendered to cover taxes upon vesting of previously granted restricted stock units.
- Price used for withholding: $90.24 per share.
- Post-transaction ownership: Smith directly holds 71,743 Medtronic ordinary shares.
No derivative security activity was reported. The filing reflects routine tax settlement rather than an open-market buy or sell, leaving the executive’s overall equity stake largely intact.